The histone lysine demethylase KDM4A serves as a coactivator for E2F1, binding to the promoters of PDK1 and PDK3, thus influencing the metabolic transition between glycolysis and mitochondrial oxidation in prostate cancer.36 The gene discussed is PDK3; the disease is prostate carcinoma.